Gilead stock jumps 5% after Q4 beat, dividend increase

Shares of Gilead Sciences Inc. GILD, rose more than 5% in the extended session Thursday after the pharma company reported fourth-quarter earnings and sales above Wall Street expectations, saying higher sales elsewhere took the sting of falling revenue for its COVID-19 drug. Gilead earned $1.6…#gilead #covid19sveklury #eps
Source: Reuters: Health - Category: Consumer Health News Source Type: news